Cme (CME) Net Cash Flow (2010 - 2026)

Cme (CME) has 17 years of Net Cash Flow data on file, last reported at $3.4 billion in Q1 2026.

• Net Cash Flow for Q1 2026 came in at $3.4 billion, down 83.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.3 billion (up 73.07% YoY), and the FY2025 annual result was $62.3 billion, up 617.21% from the prior year.
• Net Cash Flow retreated to $3.4 billion in Q1 2026 per CME's latest filing, from $12.6 billion in the prior quarter.
• Over five years, Net Cash Flow peaked at $22.0 billion in Q2 2025 and troughed at -$29.5 billion in Q2 2022.
• A 5-year average of $390.8 million and a median of $2.8 billion in 2024 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow slumped 1527.99% in 2023, then surged 147958.82% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$4.1 billion in 2022, then soared by 187.35% to $3.6 billion in 2023, then sank by 99.76% to $8.5 million in 2024, then surged by 147958.82% to $12.6 billion in 2025, then plunged by 73.35% to $3.4 billion in 2026.
• Business Quant data shows CME's Net Cash Flow at $3.4 billion in Q1 2026, $12.6 billion in Q4 2025, and $7.3 billion in Q3 2025.